Abstract

Transplantation of adventitial pericytes (APCs) improves recovery from tissue ischemia in preclinical animal models by still unknown mechanisms. This study investigates the role of the adipokine leptin (LEP) in the regulation of human APC biological functions. Transcriptomic analysis of APCs showed components of the LEP signalling pathway are modulated by hypoxia. Kinetic studies indicate cultured APCs release high amounts of immunoreactive LEP following exposure to hypoxia, continuing upon return to normoxia. Secreted LEP activates an autocrine/paracrine loop through binding to the LEP receptor (LEPR) and induction of STAT3 phosphorylation. Titration studies using recombinant LEP and siRNA knockdown of LEP or LEPR demonstrate the adipokine exerts important regulatory roles in APC growth, survival, migration and promotion of endothelial network formation. Heterogeneity in LEP expression and secretion may influence the reparative proficiency of APC therapy. Accordingly, the levels of LEP secretion predict the microvascular outcome of APCs transplantation in a mouse limb ischemia model. Moreover, we found that the expression of the Lepr gene is upregulated on resident vascular cells from murine ischemic muscles, thus providing a permissive milieu to transplanted LEP-expressing APCs. Results highlight a new mechanism responsible for APC adaptation to hypoxia and instrumental to vascular repair.

Details

Title
The adipokine leptin modulates adventitial pericyte functions by autocrine and paracrine signalling
Author
Riu, Federica 1 ; Slater, Sadie C. 2   VIAFID ORCID Logo  ; Garcia, Eva Jover 2 ; Rodriguez-Arabaolaza, Iker 2 ; Alvino, Valeria 2 ; Avolio, Elisa 2 ; Mangialardi, Giuseppe 2 ; Cordaro, Andrea 2 ; Satchell, Simon 2 ; Zebele, Carlo 2 ; Caporali, Andrea 3 ; Angelini, Gianni 2 ; Madeddu, Paolo 2 

 University of Bristol, Bristol Royal Infirmary, Bristol Heart Institute, School of Clinical Sciences, Bristol, United Kingdom (GRID:grid.5337.2) (ISNI:0000 0004 1936 7603); University of Nottingham, Cancer Biology, Division of Cancer and Stem Cells, School of Medicine University of Nottingham, Nottingham, United Kingdom (GRID:grid.4563.4) (ISNI:0000 0004 1936 8868) 
 University of Bristol, Bristol Royal Infirmary, Bristol Heart Institute, School of Clinical Sciences, Bristol, United Kingdom (GRID:grid.5337.2) (ISNI:0000 0004 1936 7603) 
 Queen’s Medical Research Institute, Centre for Cardiovascular Science, Edinburgh, United Kingdom (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988) 
Pages
5443
Publication year
2017
Publication date
2017
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2963023745
Copyright
© The Author(s) 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.